- EDAP to Present at the Jefferies Global Healthcare Conference
- EDAP Reports First Quarter 2024 Financial Results
- EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting
- EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024
- EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting
- EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results
- EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
- EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
- EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis
- EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues
More ▼
Key statistics
On Wednesday, Edap Tms SA (EDAP:NMQ) closed at 6.02, 67.22% above the 52 week low of 3.60 set on Nov 14, 2023.
52-week range
Open | 5.93 |
---|---|
High | 6.28 |
Low | 5.93 |
Bid | 5.55 |
Offer | 6.25 |
Previous close | 6.01 |
Average volume | 46.56k |
---|---|
Shares outstanding | 37.10m |
Free float | 12.42m |
P/E (TTM) | -- |
Market cap | 222.99m USD |
EPS (TTM) | -0.5346 USD |
Data delayed at least 15 minutes, as of May 22 2024 21:00 BST.
More ▼